From his baronial boardroom in Pune, Adar Poonawalla can seem out on the beautifully manicured turf of India’s largest stud farm. About the a long time, the family’s racehorses have won the Indian Derby ten moments. These days, nevertheless, the thoroughbreds gambolling across the paddock beneath his window could be the very last issue on his mind.
As the planet gears up for a race to vaccinate billions of persons from Covid-19, the 40-yr-aged scion of India’s Poonawalla pharmaceuticals dynasty has emerged as a key participant. As chief executive of Serum Institute of India (SII), the world’s major vaccine producer by volume, Poonawalla’s factory 70 miles outside the house Mumbai has been managing at entire tilt, scrambling to deliver 50m doses per thirty day period of the AstraZeneca/University of Oxford vaccine which it is hoped will help carry the killer virus beneath command.
Indications of the pressures going through the